In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Global Clinical Chemistry Analyzers Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... includes both historical and forecast data of various market segments, while the qualitative analysis of market dynamics including growth drivers, challenges, constraints, etc. provides in-depth insight into the market situation and prospects. Besides, the study ... Read More
-
Veterinary Services
... Animal Hospitals (all based in the US), as well as CVS Group plc (UK) and Greencross Vets (Australia). COMPETITIVE LANDSCAPE Demand is driven mainly by the number of cats and dogs kept as pets, which ... Read More
-
South Africa In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... The COVID-19 pandemic turned the spotlight on the IVD market since there was an increasing demand for IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV-2 virus infection among the global population. ... Read More
-
Creatinine Assay Kits
... at a CAGR of 2.2% over the analysis period 2024-2030. Jaffe`s Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the ... Read More
-
Critical Care Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Immunoproteins, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$713.5 Million by the end of the ... Read More
-
E. Coli Testing
... at a CAGR of 5.0% over the analysis period 2024-2030. Environmental Testing, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Enteric Disease Testing
... at a CAGR of 4.8% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Fertility Testing
... CAGR of 6.3% over the analysis period 2024-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end of the ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Clostridium Diagnostics
... CAGR of 14.2% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$9.1 Billion by the end of the analysis ... Read More
-
Paper Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More
-
Platelet Aggregation Devices
... at a CAGR of 5.0% over the analysis period 2024-2030. Platelet Aggregation Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$465.4 Million by the end ... Read More
-
Point-of-Care/Rapid Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Rapid Tests
... CAGR of 5.9% over the analysis period 2024-2030. PCR-based Rapid Tests, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$20.0 Billion by the end of the ... Read More
-
Specimen Validity Testing
... at a CAGR of 5.0% over the analysis period 2024-2030. Specimen Validity Testing Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$2.9 Billion by the ... Read More
-
Immunohematology Analyzers and Reagents
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Immunohematology Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the ... Read More
-
Radioimmunoassays
... 3.2% over the analysis period 2024-2030. Radioimmunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$458.7 Million by the end of the analysis ... Read More
-
Oxidative Stress Assays
... at a CAGR of 8.4% over the analysis period 2024-2030. Oxidative Stress Assays Consumables, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.3 Billion by the ... Read More
-
Malaria Diagnostics
... CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the ... Read More
-
Mycoplasma Testing
... CAGR of 8.6% over the analysis period 2024-2030. Mycoplasma Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million by the ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Hematology Testing Products
... at a CAGR of 4.4% over the analysis period 2024-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$9.8 Billion by ... Read More
-
Hemostasis Products
... CAGR of 3.7% over the analysis period 2024-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the ... Read More
-
Home Pregnancy Tests (HPT)
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More
Research Assistance
